Dominant Store Expansion and Development of Priority Regions
First written in FY2016. 7 of 13 entries say "Restated". Latest entry: FY2026.
2 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The acquisition of 三幸メディカルグループ, announced on 30 January 2026, will strengthen the pharmaceutical distribution system and improve earnings through cooperation with its pharmaceutical wholesaling business, while also contributing to the promotion of our dominant strategy in the Kanto area. We expect it to contribute to earnings going forward.」
The Company has given concrete form to its policy of linking the acquisition of the 三幸メディカル Group to a stronger cluster strategy in the Kanto region. - FY2025RestatedAnnual report
「The Company believes that inheriting the dispensing pharmacy business of the 寛一商店 Group will provide the management resources needed to leverage further economies of scale. In addition to expansion, it also expects synergies, including business reinforcement and development through a stronger cluster strategy.」
The Company continues its existing strategy of expecting synergies, including a stronger cluster strategy, from the transfer of the 寛一商店 Group’s business, in addition to expanding the number of stores. - FY2025-H1AdvancedAnnual report
「The Company expects the acquisition of stores from the 寛一商店 Group to generate synergies, including business reinforcement and development through a stronger cluster strategy, rather than merely expanding its footprint, and believes this will contribute to increasing the Group’s corporate value.」
The Company has given concrete form to its policy of expecting synergies, including a stronger cluster strategy, from the acquisition of stores from the 寛一商店 Group, rather than simply expanding the number of stores. - FY2024RestatedAnnual report
「To this end, the Company will gather information on newly opening clinics and hospitals and work to develop stores that are more closely connected with their local communities.」
Regarding its cluster strategy, the Company continues to develop community-based stores by gathering information on newly opening clinics and hospitals. - FY2023RestatedAnnual report
「The Group will strengthen its cluster strategy to further enhance its existing store network and contribute to community healthcare as patients’ primary pharmacy.」
The Company continues to treat the enhancement of its existing store network and strengthening of its cluster strategy as key priorities. - FY2022RestatedAnnual report
「The Group will strengthen its cluster strategy to further enhance its existing store network and contribute to community healthcare as patients’ primary pharmacy.」
The Company continues to enhance its existing store network, develop priority regions and strengthen its cluster strategy. - FY2021RestatedAnnual report
「The Group continues to open new stores in clusters and pursue M&A, as it has done in the past,」
The Company has indicated a policy of continuing to open new stores in clusters and pursue M&A. - FY2020RestatedAnnual report
「We will strengthen our dominant-store strategy in order to further enhance our existing store network and contribute to community healthcare as family pharmacies.」
The Company continues its policy of strengthening a cluster strategy based on its existing store network. - FY2018RestatedAnnual report
「We will strengthen our dominant-store strategy in order to further enhance our existing store network and contribute to community healthcare as family pharmacies.」
The Company continues to focus on strengthening its existing store network and cluster strategy. - FY2016First statedAnnual report
「We will strengthen our dominant-store strategy in order to further enhance our existing store network and contribute to community healthcare as family pharmacies.」
The group identifies regions with low rates of separation between prescribing and dispensing as priority development areas and plans to open stores closely integrated with local communities.